SCHEMBL9112426

SCHEMBL9112426

C#CC(O)(c1ccccc1C)c1ccccc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.39
▸ ACHE P22303 2/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ GABRB2 P47870 1/20 0.39
▸ CASR P41180 1/20 0.38
▸ CHRM3 P20309 2/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ CA2 P00918 2/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA7 P43166 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11082289 0.88 ALDH1A1 (0.38) TSHRACHEGABRA1GABRB2CASR
SCHEMBL18883812 0.88 GABRA1 (0.38) TSHRACHEGABRA1GABRB2CASR
SCHEMBL2301124 0.77 MEN1 (0.40) CASRTRPA1ALDH1A1TDP1MEN1
SCHEMBL8785533 0.75 TSHR (0.47) TSHRACHEGABRA1GABRB2CASR
SCHEMBL11138245 0.75 TSHR (0.47) TSHRACHEGABRA1GABRB2CASR
SCHEMBL10437577 0.75 ACHE (0.47) TSHRACHEGABRA1GABRB2CASR
SCHEMBL31589377 0.75 TSHR (0.47) TSHRACHEGABRA1GABRB2CASR
SCHEMBL15875002 0.74 CHRM2 (0.37) TSHRACHEGABRA1GABRB2CHRM3
SCHEMBL17352347 0.74 CASR (0.36) TSHRACHEGABRA1GABRB2CASR
SCHEMBL796229 0.73 GABRA1 (0.48) TSHRACHEGABRA1GABRB2CASR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107250142-B Group 8 transition metal catalyst, method for producing same and use thereof in metathesis reactions 光明创新(武汉)有限公司 2020-10-30 — — CN disclosed
US-10159966-B2 Catalyst complexes with carbene ligand and method for making same and use in metathesis reaction GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2018-12-25 — — US disclosed
US-10160828-B2 Group 8 transition metal catalysts and method for making same and process for use of same in metathesis reaction GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2018-12-25 — — US disclosed
US-20170145152-A1 GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2017-05-25 — — US disclosed
US-20170145152-A1 GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2017-05-25 — — US disclosed
US-20170145152-A1 GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2017-05-25 — — US disclosed
EP-3164409-A1 GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION Guang Ming Innovation Company (Wuhan) (CN) 2017-05-10 — — EP disclosed
WO-2016000242-A1 GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2016-01-07 — — WO disclosed
WO-2016000242-A1 GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2016-01-07 — — WO disclosed
US-20150367338-A1 CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2015-12-24 — — US disclosed
US-20150367338-A1 CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2015-12-24 — — US disclosed
US-20150367338-A1 CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2015-12-24 — — US disclosed
EP-2943499-A1 CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION Guangming Innovation Company (Wuhan) (CN) 2015-11-18 — — EP disclosed
WO-2014108071-A1 CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2014-07-17 — — WO disclosed
WO-2014108071-A1 CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION GUANG MING INNOVATION COMPANY (WUHAN) (CN) 2014-07-17 — — WO disclosed
WO-1995016215-A1 NOVEL SUBSTITUTED NAPHTHOPYRANS PPG INDUSTRIES, INC. (US) 1995-06-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10159966-B2 Catalyst complexes with carbene ligand and method for making same and use in metathesis reaction MSMO1, ALOX12, SQLE TSHR 3989/4885ACHE 1840/4885GABRA1 1343/4885
US-20170145152-A1 GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION F8, COASY, FADS1 TSHR 4178/4885ACHE 4060/4885GABRA1 1946/4885
US-20150367338-A1 CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION MSMO1, ALOX12, SQLE TSHR 3989/4885ACHE 1840/4885GABRA1 1343/4885
US-10160828-B2 Group 8 transition metal catalysts and method for making same and process for use of same in metathesis reaction F8, COASY, FADS1 TSHR 4178/4885ACHE 4060/4885GABRA1 1946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback